Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Post Market, Long Term, Prospective, Observational, Multi-site Outcome Study to Follow the Clinical Course and Seizure Reduction of Patients With Refractory Seizures Who Are Being Treated With Adjunctive VNS Therapy.

NCT01281293 is registered in ClinicalTrials.gov with Cyberonics, Inc. as lead sponsor.

NCT NCT01281293
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01281293 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Post Market, Long Term, Prospective, Observational, Multi-site Outcome Study to Follow the Clinical Course and Seizure Reduction of Patients With Refractory Seizures Who Are Being Treated With Adjunctive VNS Therapy.
Lead sponsor
Cyberonics, Inc.
Phase
Observational
Overall status
Completed
Start date
January 31, 2011
Completion date
August 16, 2018
Enrollment
124 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy